BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34771084)

  • 1. Biosynthetic Mechanisms and Biological Significance of Glycerol Phosphate-Containing Glycan in Mammals.
    Imae R; Manya H; Endo T
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDP-glycerol inhibits the synthesis of the functional
    Imae R; Manya H; Tsumoto H; Osumi K; Tanaka T; Mizuno M; Kanagawa M; Kobayashi K; Toda T; Endo T
    J Biol Chem; 2018 Aug; 293(31):12186-12198. PubMed ID: 29884773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCYT2 synthesizes CDP-glycerol in mammals and reduced PCYT2 enhances the expression of functionally glycosylated α-dystroglycan.
    Imae R; Manya H; Tsumoto H; Miura Y; Endo T
    J Biochem; 2021 Oct; 170(2):183-194. PubMed ID: 34255834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Malignancy Is Correlated with Upregulation of PCYT2-Mediated Glycerol Phosphate Modification of α-Dystroglycan.
    Umezawa F; Natsume M; Fukusada S; Nakajima K; Yamasaki F; Kawashima H; Kuo CW; Khoo KH; Shimura T; Yagi H; Kato K
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a novel monoclonal antibody against truncated glycoforms of α-dystroglycan lacking matriglycans.
    Yamasaki F; Umezawa F; Sensui T; Anzo M; Abo H; Kuo CW; Khoo KH; Kato K; Yagi H; Kawashima H
    Biochem Biophys Res Commun; 2021 Nov; 579():8-14. PubMed ID: 34583196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan.
    Manya H; Endo T
    Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian O-mannosyl glycans: Biochemistry and glycopathology.
    Endo T
    Proc Jpn Acad Ser B Phys Biol Sci; 2019; 95(1):39-51. PubMed ID: 30643095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycobiology of α-dystroglycan and muscular dystrophy.
    Endo T
    J Biochem; 2015 Jan; 157(1):1-12. PubMed ID: 25381372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory machinery for the functional dystroglycan glycosylation.
    Kondo Y; Okajima T
    J Biochem; 2023 Apr; 173(5):333-335. PubMed ID: 36760122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding.
    Patnaik SK; Stanley P
    J Biol Chem; 2005 May; 280(21):20851-9. PubMed ID: 15788414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.
    Zhang P; Hu H
    Glycobiology; 2012 Feb; 22(2):235-47. PubMed ID: 21930648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan.
    Yagi H; Nakagawa N; Saito T; Kiyonari H; Abe T; Toda T; Wu SW; Khoo KH; Oka S; Kato K
    Sci Rep; 2013 Nov; 3():3288. PubMed ID: 24256719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-mannosyl glycans in mammals.
    Endo T
    Biochim Biophys Acta; 1999 Dec; 1473(1):237-46. PubMed ID: 10580142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HNK-1 sulfotransferase-dependent sulfation regulating laminin-binding glycans occurs in the post-phosphoryl moiety on α-dystroglycan.
    Nakagawa N; Takematsu H; Oka S
    Glycobiology; 2013 Sep; 23(9):1066-74. PubMed ID: 23723439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous reductase activities for the generation of ribitol-phosphate, a CDP-ribitol precursor, in mammals.
    Hoshino S; Manya H; Imae R; Kobayashi K; Kanagawa M; Endo T
    J Biochem; 2024 Mar; 175(4):418-425. PubMed ID: 38140954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Muscular Dystrophy Gene TMEM5 Encodes a Ribitol β1,4-Xylosyltransferase Required for the Functional Glycosylation of Dystroglycan.
    Manya H; Yamaguchi Y; Kanagawa M; Kobayashi K; Tajiri M; Akasaka-Manya K; Kawakami H; Mizuno M; Wada Y; Toda T; Endo T
    J Biol Chem; 2016 Nov; 291(47):24618-24627. PubMed ID: 27733679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase.
    Bao X; Kobayashi M; Hatakeyama S; Angata K; Gullberg D; Nakayama J; Fukuda MN; Fukuda M
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12109-14. PubMed ID: 19587235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.
    Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP
    Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of site-specific O-glycan structures within the mucin-like domain of alpha-dystroglycan from human skeletal muscle.
    Nilsson J; Nilsson J; Larson G; Grahn A
    Glycobiology; 2010 Sep; 20(9):1160-9. PubMed ID: 20507882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced glycosylation of α-dystroglycans on carcinoma cells contributes to formation of highly infiltrative histological patterns in prostate cancer.
    Shimojo H; Kobayashi M; Kamigaito T; Shimojo Y; Fukuda M; Nakayama J
    Prostate; 2011 Aug; 71(11):1151-7. PubMed ID: 21656825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.